Evidence map›Paper›PMID 40255901›Full record

ArticleJournal of hepatocellular carcinoma2025

Prognostic Analysis of Elderly Patients with Hepatocellular Carcinoma: an Exploration and Machine Learning Model Prediction Based on Age Stratification and Surgical Approach.

Chiyu Cai, Hengli Zhu, Bingyao Li, Changqian Tang, Yongnian Ren, Yuqi Guo, Jizhen Li, Liancai Wang, Deyu Li, Dongxiao Li

Abstract read
In one paragraph

Article in Journal of hepatocellular carcinoma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chiyu Cai *Department of Hepatobiliary and Pancreatic Surgery, Zhengzhou University People's Hospital, Zhengzhou, Henan, People's Republic of China.
Hengli Zhu *Department of Hepatobiliary and Pancreatic Surgery, Zhengzhou University People's Hospital, Zhengzhou, Henan, People's Republic of China.
Bingyao Li *Henan Provincial People's Hospital, Xinxiang Medical University, Zhengzhou, Henan, People's Republic of China.
Changqian TangDepartment of Hepatobiliary and Pancreatic Surgery, Henan University People's Hospital, Zhengzhou, Henan, People's Republic of China.
Yongnian RenDepartment of Hepatobiliary and Pancreatic Surgery, Zhengzhou University People's Hospital, Zhengzhou, Henan, People's Republic of China.
Yuqi GuoDepartment of Hepatobiliary and Pancreatic Surgery, Zhengzhou University People's Hospital, Zhengzhou, Henan, People's Republic of China.
Jizhen LiDepartment of Hepatobiliary and Pancreatic Surgery, Zhengzhou University People's Hospital, Zhengzhou, Henan, People's Republic of China.
Liancai WangDepartment of Hepatobiliary and Pancreatic Surgery, Zhengzhou University People's Hospital, Zhengzhou, Henan, People's Republic of China.
Deyu LiDepartment of Hepatobiliary and Pancreatic Surgery, Zhengzhou University People's Hospital, Zhengzhou, Henan, People's Republic of China.
Dongxiao LiDepartment of Gastroenterology, Zhengzhou University People's Hospital, Zhengzhou, Henan, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: As the global population ages, precise prognostic tools are needed to optimize postoperative care for elderly hepatocellular carcinoma (HCC) patients. This study established a machine learning-driven predictive model to identify key prognostic determinants and evaluate age/surgical approach impacts, overcoming limitations of traditional statistical methods. Methods: This retrospective study included 252 postoperative HCC patients aged ≥65 years (mean age 69.0±4.3; 68.25% male). Patients were randomly divided into training (70%, n=177) and validation sets (30%, n=75). We evaluated 147 machine learning models to establish the optimal predictive model. Patients were grouped by age (>75 vs ≤75 years) and surgical approach (laparoscopic vs open). Results: The LASSO+RSF model showed strong predictive performance with AUC values of 0.869 and 0.818 in the training and validation sets, respectively. Time-dependent AUCs for 1-, 2- and 3-year survival were 0.874, 0.903, and 0.883 in the training set, and 0.878, 0.882, and 0.915 in the validation set. Key predictors included age-adjusted Charlson index (ACCI, LASSO+RSF synergistic weight (LRSW) =0.160), microvascular invasion (0.111), tumor capsule integrity (0.034), and lymphatic invasion (0.023), while three variables (intraoperative blood loss, tumor margin, WBC) were excluded (LRSW<0.01). A web-based dynamic nomogram (https://cliniometrics.shinyapps.io/LRSF-GeroHCC/) enabled real-time risk stratification. Patients >75 years had longer length of stay (16 vs 14 days, Conclusion: The LASSO+RSF model provides validated tools for personalized prognosis management in elderly HCC patients, emphasizing age-adapted surgical strategies and comorbidity-focused perioperative care.

Indexed as

age-adjusted Charlson comorbidity indexgeriatric oncologyhepatocellular carcinomamachine learningminimally invasive surgerysurvival prediction

Identifiers

PMID40255901
PMCPMC12007611

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.